136 related articles for article (PubMed ID: 10023784)
1. Who will benefit from DNase?
Rubin BK
Pediatr Pulmonol; 1999 Jan; 27(1):3-4. PubMed ID: 10023784
[No Abstract] [Full Text] [Related]
2. Dornase in non-CF.
Ratjen F
Pediatr Pulmonol Suppl; 2004; 26():154-5. PubMed ID: 15029636
[No Abstract] [Full Text] [Related]
3. DNase treatment in primary ciliary dyskinesia--assessment by nocturnal pulse oximetry.
ten Berge M; Brinkhorst G; Kroon AA; de Jongste JC
Pediatr Pulmonol; 1999 Jan; 27(1):59-61. PubMed ID: 10023793
[No Abstract] [Full Text] [Related]
4. Rational use of mucoactive medications to treat pediatric airway disease.
Linssen RSN; Ma J; Bem RA; Rubin BK
Paediatr Respir Rev; 2020 Nov; 36():8-14. PubMed ID: 32653467
[TBL] [Abstract][Full Text] [Related]
5. The clinical use of rhDNAse.
Davies J; Trindale M; Wallis C; Rosenthal M; Bush A
Pediatr Pulmonol Suppl; 1997; 16():273-4. PubMed ID: 9443309
[No Abstract] [Full Text] [Related]
6. Recombinant human DNase in management of lobar atelectasis due to retained secretions.
Touleimat BA; Conoscenti CS; Fine JM
Thorax; 1995 Dec; 50(12):1319-21; discussion 1323. PubMed ID: 8553310
[TBL] [Abstract][Full Text] [Related]
7. [Cystic fibrosis. Current indications for nebulized treatments: antibiotics and DNase].
Sardet-Frismand A
Rev Mal Respir; 1999 Jan; 16 Suppl 3():S131-2. PubMed ID: 10088286
[No Abstract] [Full Text] [Related]
8. Adjunctive therapy in cystic firbrosis (CF).
Voter KZ
Pediatr Infect Dis J; 1998 Apr; 17(4):341-2. PubMed ID: 9576391
[No Abstract] [Full Text] [Related]
9. Recombinant human DNase (rhDNase) in cystic fibrosis: is it cost effective?
Conway SP
Arch Dis Child; 1997 Jul; 77(1):1-3. PubMed ID: 9279142
[No Abstract] [Full Text] [Related]
10. Aerosolized deoxyribonuclease for cystic fibrosis.
Med Lett Drugs Ther; 1994 Apr; 36(920):34-5. PubMed ID: 8145672
[No Abstract] [Full Text] [Related]
11. Consensus conference: practical applications of Pulmozyme. September 22, 1993.
Ramsey BW; Dorkin HL
Pediatr Pulmonol; 1994 Jun; 17(6):404-8. PubMed ID: 8090614
[No Abstract] [Full Text] [Related]
12. Dornase in treatment of chronic bronchitis.
Hudson TJ
Ann Pharmacother; 1996 Jun; 30(6):674-5. PubMed ID: 8792955
[TBL] [Abstract][Full Text] [Related]
13. Early treatment with dornase alfa in cystic fibrosis: what are the issues?
Bush A
Pediatr Pulmonol; 1998 Feb; 25(2):79-82. PubMed ID: 9516089
[No Abstract] [Full Text] [Related]
14. Effects of recombinant human DNase therapy on healthcare use and costs in patients with cystic fibrosis.
Oster G; Huse DM; Lacey MJ; Regan MM; Fuchs HJ
Ann Pharmacother; 1995 May; 29(5):459-64. PubMed ID: 7655127
[TBL] [Abstract][Full Text] [Related]
15. Dornase alfa therapy in cystic fibrosis: who should get it?
Kanga JF
Chest; 1996 Oct; 110(4):871-2. PubMed ID: 8874235
[No Abstract] [Full Text] [Related]
16. Dornase alfa in premature infants with severe respiratory distress and early bronchopulmonary dysplasia.
Reiter PD; Townsend SF; Velasquez R
J Perinatol; 2000 Dec; 20(8 Pt 1):530-4. PubMed ID: 11190594
[No Abstract] [Full Text] [Related]
17. Evidence-based medicine.
Marino JT
Pediatr Pulmonol; 1998 Sep; 26(3):231-3. PubMed ID: 9773922
[No Abstract] [Full Text] [Related]
18. rhDNase in cystic fibrosis.
Tyrrell JC; Lewis PA; Sheldon CD; Connett G
Thorax; 1999 Aug; 54(8):752. PubMed ID: 10490419
[No Abstract] [Full Text] [Related]
19. Dornase alpha in the management of a mechanically ventilated infant with cystic fibrosis.
Kling S; Gie RP; Riphagen S
Pediatr Pulmonol; 1997 Aug; 24(2):124-5. PubMed ID: 9292906
[No Abstract] [Full Text] [Related]
20. Rescue use of DNase in critical lung atelectasis and mucus retention in premature neonates.
El Hassan NO; Chess PR; Huysman MW; Merkus PJ; de Jongste JC
Pediatrics; 2001 Aug; 108(2):468-70. PubMed ID: 11483817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
